TEVA-Codeine Tablets: out of specification on friability test (broken tablet) during stability testing for affected lots.

Product safety

Date

2024-12-20

Country

Canada

Product

TEVA-Codeine Tablets

Classification

Type II

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2024-12-24
2. CA
   Drugs & medicalType II

   QAngio XA 3D

   Performance

   Health CanadaOfficial notice →
3. CA
   Drugs & medicalType I

   Neo-Tee T-Piece Resuscitator

   Performance

   Health CanadaOfficial notice →
4. 2024-12-23
5. CA
   Drugs & medicalType II

   Jamp Amoxi Clav Suspension; Out of specification

   Product quality

   Health CanadaOfficial notice →
6. 2024-12-19
7. CA
   Drugs & medicalType II

   DLP™ Elongated One Piece Arterial Cannulae

   Labelling and packaging

   Health CanadaOfficial notice →
8. CA
   Drugs & medicalType II

   Vitros® Chemistry Products System - DGXN Slides (Digoxin)

   Labelling and packaging

   Health CanadaOfficial notice →
9. CA
   Drugs & medicalType II

   Biodesign® Hiatal Hernia Graft

   Labelling and packaging

   Health CanadaOfficial notice →